Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/72139 |
Resumo: | OBJECTIVE: Ischemic stroke may result from transient or permanent reductions of regional cerebral blood flow. Polymorphonuclear neutrophils have been described as the earliest inflammatory cells to arrive in ischemic tissue. CXCR1/2 receptors are involved in the recruitment of these cells. However, the contribution of these chemokine receptors during transient brain ischemia in mice remains poorly understood. In this work, we investigated the effects of reparixin, an allosteric antagonist of CXCR1/2 receptors, in a model of middle cerebral artery occlusion and reperfusion in mice. METHODS: C57BL/6J male mice treated with reparixin or vehicle were subjected to a middle cerebral artery occlusion procedure 1 h after the treatment. Ninety minutes after ischemia induction, the monofilament that prevented blood flow was removed. Twenty-four hours after the reperfusion procedure, behavioral changes, including motor signs, were analyzed with the SmithKline/Harwell/lmperial College/Royal Hospital/Phenotype Assessment (SHIRPA) battery. The animals were sacrificed, and brain tissue was removed for histological and biochemical analyses. Histological sections were stained with hematoxylin and eosin, neutrophil infiltration was estimated by myeloperoxidase activity and the inflammatory cytokine IL-iβ was measured by ELISA. RESULTS: Pre-treatment with reparixin reduced the motor deficits observed in this model of ischemia and reperfusion. Myeloperoxidase activity and IL-iβ were reduced in the reparixin-treated group. Histological analysis revealed that ischemic injury was also attenuated by reparixin pre-treatment. CONCLUSIONS: Our results suggest that the blockade of the CXCR1/2 receptors by reparixin promotes neuroprotective effects by reducing the levels of polymorphonuclear infiltration in the brain and the tissue damage associated with middle cerebral artery occlusion and reperfusion. |
id |
USP-19_647cc7069cfdec8b614db6a465e8b46a |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/72139 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in miceCerebral IschemiaNeutrophilsReparixinCXCR1/CXCR2 ReceptorsOBJECTIVE: Ischemic stroke may result from transient or permanent reductions of regional cerebral blood flow. Polymorphonuclear neutrophils have been described as the earliest inflammatory cells to arrive in ischemic tissue. CXCR1/2 receptors are involved in the recruitment of these cells. However, the contribution of these chemokine receptors during transient brain ischemia in mice remains poorly understood. In this work, we investigated the effects of reparixin, an allosteric antagonist of CXCR1/2 receptors, in a model of middle cerebral artery occlusion and reperfusion in mice. METHODS: C57BL/6J male mice treated with reparixin or vehicle were subjected to a middle cerebral artery occlusion procedure 1 h after the treatment. Ninety minutes after ischemia induction, the monofilament that prevented blood flow was removed. Twenty-four hours after the reperfusion procedure, behavioral changes, including motor signs, were analyzed with the SmithKline/Harwell/lmperial College/Royal Hospital/Phenotype Assessment (SHIRPA) battery. The animals were sacrificed, and brain tissue was removed for histological and biochemical analyses. Histological sections were stained with hematoxylin and eosin, neutrophil infiltration was estimated by myeloperoxidase activity and the inflammatory cytokine IL-iβ was measured by ELISA. RESULTS: Pre-treatment with reparixin reduced the motor deficits observed in this model of ischemia and reperfusion. Myeloperoxidase activity and IL-iβ were reduced in the reparixin-treated group. Histological analysis revealed that ischemic injury was also attenuated by reparixin pre-treatment. CONCLUSIONS: Our results suggest that the blockade of the CXCR1/2 receptors by reparixin promotes neuroprotective effects by reducing the levels of polymorphonuclear infiltration in the brain and the tissue damage associated with middle cerebral artery occlusion and reperfusion.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/7213910.1590/clin.v68i3.72139Clinics; Vol. 68 No. 3 (2013); 391-394Clinics; v. 68 n. 3 (2013); 391-394Clinics; Vol. 68 Núm. 3 (2013); 391-3941980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/72139/75374Sousa, Larissa Fonseca da CunhaCoelho, Fernanda MatosRodrigues, David HenriqueCampos, Alline CristinaBarcelos, Luciola da SilvaTeixeira, Mauro MartinsRachid, Milene AlvarengaTeixeira, Antonio Lucioinfo:eu-repo/semantics/openAccess2014-01-28T17:05:37Zoai:revistas.usp.br:article/72139Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2014-01-28T17:05:37Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice |
title |
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice |
spellingShingle |
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice Sousa, Larissa Fonseca da Cunha Cerebral Ischemia Neutrophils Reparixin CXCR1/CXCR2 Receptors |
title_short |
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice |
title_full |
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice |
title_fullStr |
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice |
title_full_unstemmed |
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice |
title_sort |
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice |
author |
Sousa, Larissa Fonseca da Cunha |
author_facet |
Sousa, Larissa Fonseca da Cunha Coelho, Fernanda Matos Rodrigues, David Henrique Campos, Alline Cristina Barcelos, Luciola da Silva Teixeira, Mauro Martins Rachid, Milene Alvarenga Teixeira, Antonio Lucio |
author_role |
author |
author2 |
Coelho, Fernanda Matos Rodrigues, David Henrique Campos, Alline Cristina Barcelos, Luciola da Silva Teixeira, Mauro Martins Rachid, Milene Alvarenga Teixeira, Antonio Lucio |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Sousa, Larissa Fonseca da Cunha Coelho, Fernanda Matos Rodrigues, David Henrique Campos, Alline Cristina Barcelos, Luciola da Silva Teixeira, Mauro Martins Rachid, Milene Alvarenga Teixeira, Antonio Lucio |
dc.subject.por.fl_str_mv |
Cerebral Ischemia Neutrophils Reparixin CXCR1/CXCR2 Receptors |
topic |
Cerebral Ischemia Neutrophils Reparixin CXCR1/CXCR2 Receptors |
description |
OBJECTIVE: Ischemic stroke may result from transient or permanent reductions of regional cerebral blood flow. Polymorphonuclear neutrophils have been described as the earliest inflammatory cells to arrive in ischemic tissue. CXCR1/2 receptors are involved in the recruitment of these cells. However, the contribution of these chemokine receptors during transient brain ischemia in mice remains poorly understood. In this work, we investigated the effects of reparixin, an allosteric antagonist of CXCR1/2 receptors, in a model of middle cerebral artery occlusion and reperfusion in mice. METHODS: C57BL/6J male mice treated with reparixin or vehicle were subjected to a middle cerebral artery occlusion procedure 1 h after the treatment. Ninety minutes after ischemia induction, the monofilament that prevented blood flow was removed. Twenty-four hours after the reperfusion procedure, behavioral changes, including motor signs, were analyzed with the SmithKline/Harwell/lmperial College/Royal Hospital/Phenotype Assessment (SHIRPA) battery. The animals were sacrificed, and brain tissue was removed for histological and biochemical analyses. Histological sections were stained with hematoxylin and eosin, neutrophil infiltration was estimated by myeloperoxidase activity and the inflammatory cytokine IL-iβ was measured by ELISA. RESULTS: Pre-treatment with reparixin reduced the motor deficits observed in this model of ischemia and reperfusion. Myeloperoxidase activity and IL-iβ were reduced in the reparixin-treated group. Histological analysis revealed that ischemic injury was also attenuated by reparixin pre-treatment. CONCLUSIONS: Our results suggest that the blockade of the CXCR1/2 receptors by reparixin promotes neuroprotective effects by reducing the levels of polymorphonuclear infiltration in the brain and the tissue damage associated with middle cerebral artery occlusion and reperfusion. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/72139 10.1590/clin.v68i3.72139 |
url |
https://www.revistas.usp.br/clinics/article/view/72139 |
identifier_str_mv |
10.1590/clin.v68i3.72139 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/72139/75374 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 68 No. 3 (2013); 391-394 Clinics; v. 68 n. 3 (2013); 391-394 Clinics; Vol. 68 Núm. 3 (2013); 391-394 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222759813382144 |